Article Versions Notes

Layton R, Beggs DS, Fisher A, Mansell P, Layton D, Durr PA, Allen T, Taylor G, Kelly ML, Williams DT, et al. Welfare Implications of Low-Dose Atipamezole Reversal of Tiletamine/Zolazepam/Xylazine Anaesthesia in Pigs. Animals. 2025; 15(2):258. https://doi.org/10.3390/ani15020258

Layton, Rachel, David S. Beggs, Andrew Fisher, Peter Mansell, Daniel Layton, Peter A. Durr, Teegan Allen, Grace Taylor, Michael L. Kelly, David T. Williams, and et al. 2025. "Welfare Implications of Low-Dose Atipamezole Reversal of Tiletamine/Zolazepam/Xylazine Anaesthesia in Pigs" Animals 15, no. 2: 258. https://doi.org/10.3390/ani15020258

Layton, R., Beggs, D. S., Fisher, A., Mansell, P., Layton, D., Durr, P. A., Allen, T., Taylor, G., Kelly, M. L., Williams, D. T., & Stanger, K. J. (2025). Welfare Implications of Low-Dose Atipamezole Reversal of Tiletamine/Zolazepam/Xylazine Anaesthesia in Pigs. Animals, 15(2), 258. https://doi.org/10.3390/ani15020258